OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION Trademark

Trademark Overview

On Thursday, February 18, 2021, a trademark application was filed for OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION with the United States Patent and Trademark Office. The USPTO has given the OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION trademark a serial number of 90533968. The federal status of this trademark filing is REGISTERED as of Tuesday, August 15, 2023. This trademark is owned by Novartis AG. The OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing health information about pharmaceuticals containing monoclonal antibodies
omb kesimpta (ofatumumab) 20 mg injection

General Information

Serial Number90533968
Word MarkOMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION
Filing DateThursday, February 18, 2021
Status700 - REGISTERED
Status DateTuesday, August 15, 2023
Registration Number7139722
Registration DateTuesday, August 15, 2023
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 19, 2021

Trademark Statements

Description of MarkThe mark consists of the stylized letters "OMB", displayed at a forty-five degree tilt, with the "O" in coral and the combined letters "MB" in teal, followed by the word "KESIMPTA" in a stylized brown font above the words "(ofatumumab) 20 mg injection" in a stylized brown font. The color white is not claimed and appears as background only.
Pseudo MarkOMB KESIMPTA (OFATUMUMAB) TWENTY MILLIGRAM INJECTION; OMB KESIMPTA (OFATUMUMAB) TWO ONE MILLIGRAM INJECTION
Indication of Colors claimedThe color(s) coral, teal and brown is/are claimed as a feature of the mark.
Translation of Words in MarkThe wording "KESIMPTA" has no meaning in a foreign language.
Goods and ServicesProviding health information about pharmaceuticals containing monoclonal antibodies
Disclaimer with Predetermined Text"OMB", "OFATUMUMAB" AND "20 MG INJECTION"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 20, 2021
Primary Code044
First Use Anywhere DateFriday, July 31, 2020
First Use In Commerce DateFriday, July 31, 2020

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBasel 4002
CH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel 4002
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4002
CH

Trademark Events

Event DateEvent Description
Tuesday, August 15, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 15, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, July 13, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, July 12, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 12, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, July 12, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 12, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, July 12, 2023SU-EXAMINER'S AMENDMENT WRITTEN
Friday, July 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 6, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 28, 2023USE AMENDMENT FILED
Thursday, July 6, 2023SOU EXTENSION 4 GRANTED
Wednesday, June 28, 2023SOU EXTENSION 4 FILED
Thursday, July 6, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 28, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 28, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, June 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 12, 2023SOU EXTENSION 3 GRANTED
Monday, June 12, 2023SOU EXTENSION 3 FILED
Monday, June 12, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 12, 2022SOU EXTENSION 2 GRANTED
Monday, December 12, 2022SOU EXTENSION 2 FILED
Monday, December 12, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, June 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, June 12, 2022SOU EXTENSION 1 GRANTED
Sunday, June 12, 2022SOU EXTENSION 1 FILED
Sunday, June 12, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 19, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 15, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 15, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 14, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 14, 2021NON-FINAL ACTION E-MAILED
Tuesday, September 14, 2021NON-FINAL ACTION WRITTEN
Tuesday, September 14, 2021ASSIGNED TO EXAMINER
Thursday, May 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 22, 2021NEW APPLICATION ENTERED

Related Keywords

injection ofatumumab kesimpta containing monoclonal antibodies pharmaceuticals about health information providing